Evidence map›Paper›PMID 41828687›Full record

ArticleInternational journal of molecular sciences2026

One-Step Multiplex PCR Reveals Selective Activation of Immunostimulatory Human Endogenous Retroviruses and Epigenetic Imbalance in Systemic Lupus Erythematosus.

Ilaria Galliano, Pierluigi Sorgato, Cristina Calvi, Marzia Pavan, Anna Pau, Anna Massobrio, Roberto Albiani, Claudia Linari, Alice Geranzani, Anna Clemente and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ilaria GallianoDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0000-0002-1273-3178
Pierluigi SorgatoDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Cristina CalviDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Marzia PavanImmunohematology and Transfusion Medicine, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Anna PauDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0009-0002-5430-6008
Anna MassobrioLaboratory Medicine, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Roberto AlbianiImmunohematology and Transfusion Medicine, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Claudia LinariLaboratory Medicine, Regina Margherita Children's Hospital, 10126 Turin, Italy.
Alice GeranzaniImmunorheumatology Unit, Regina Margherita Children's Hospital, University Hospital City of Health and Sciences of Turin, 10126 Turin, Italy.
Anna ClementeDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Paola MontanariDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Stefano GambarinoDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.
Francesco LicciardiImmunorheumatology Unit, Regina Margherita Children's Hospital, University Hospital City of Health and Sciences of Turin, 10126 Turin, Italy.
Massimiliano BergalloDepartment of Public Health and Pediatric Sciences, University of Turin, Piazza Polonia 94, 10126 Turin, Italy.ORCID 0000-0002-9291-1332

Funding

Regione Autonoma della Sardegna BERM_RIC_N_COMP_REND_23_01University of Turin BERM_RILO_22_01
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is characterized by chronic immune activation, enhanced type I interferon signaling, and epigenetic dysregulation, conditions that may promote the reactivation of human endogenous retroviruses (HERVs). Whether HERV activation in SLE is global or selective, however, remains unclear. We analyzed the expression of HERV-H, HERV-K, and HERV-W, along with the HERV-derived envelope genes Syncytin-1 and Syncytin-2, in samples from lupus patients and healthy controls. In parallel, we assessed the expression of the epigenetic repressors TRIM28 and SETDB1. HERV-H expression was comparable between groups, whereas HERV-K and HERV-W were significantly overexpressed in lupus patients. Syncytin-1 and HERV-W env transcripts were markedly increased in SLE, while Syncytin-2 expression was unchanged. Lupus patients showed reduced TRIM28 and increased SETDB1 expression, consistent with altered regulation of HERV repression pathways. Notably, HERV-H and HERV-W pol expression correlated with the type I interferon score, suggesting an association between interferon signaling and selective HERV activation. These findings indicate that SLE is associated with the selective activation of immunostimulatory HERV families, particularly HERV-W. The observed associations with interferon signaling suggest that HERV-W-related transcripts may represent disease-associated molecular signatures, warranting further mechanistic investigation.

Indexed as

Endogenous RetrovirusesEpigenesis, GeneticLupus Erythematosus, SystemicMultiplex Polymerase Chain ReactionAdultFemaleGene Products, envHistone-Lysine N-MethyltransferaseHumansInterferon Type IMaleMiddle AgedPregnancy ProteinsTripartite Motif-Containing Protein 28Gene Products, envHistone-Lysine N-MethyltransferaseInterferon Type IPregnancy ProteinsSETDB1 protein, humansyncytinTRIM28 protein, humanTripartite Motif-Containing Protein 28epigenetic dysregulationHERV-Whuman endogenous retroviruses (HERVs)one-step multiplex PCRSyncytin-1systemic lupus erythematosus

Identifiers

PMID41828687
PMCPMC12986076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.